by 
The Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membrane and bone graft substitutes are tissue regeneration products used in dental surgery procedures including implant dentistry, extraction site management, ridge augmentation, and periodontal defect regeneration. Membranes create seclusion and protection of a bony defect site from soft tissue ingrowth during the healing process. Bone graft substitutes offer synthetic or natural matrices that enhance new bone formation. Common membrane types include absorbable/non-resorbable and synthetic/biologic while bone graft substitutes can be autografts, allografts, xenografts, synthetic and tissue engineered options. These products enable proper formation of new bone at defect sites improving implantation success rates and aesthetic outcomes in complex dental procedures.
Market Dynamics:
The dental membrane and bone graft substitute market is primarily driven by the growing prevalence of dental diseases and rising demand for dental implantation procedures. According to the Global Burden of Disease Study, oral diseases affected over 3.5 billion people worldwide in 2015 with dental caries in permanent teeth being the most common condition. Further, the number of dental implants placed annually has risen substantially over the past decade with over 3 million cases performed in the US in 2018. Regenerative products enable effective treatment of bone defects and gum recession facilitating implant functionality and longevity. Additionally, technological advancements in materials science have improved membrane/graft properties supporting bone healing and remodeling. Newer tissue engineered and stem-cell based graft options also offer enhanced clinical efficacy. However, high procedure costs and limited reimbursements still pose challenges for market growth in certain regions.
Segment Analysis
The global dental membrane and bone graft substitute market can be segmented into membrane and bone graft substitutes. Membranes are further segmented into resorbable membranes and non-resorbable membranes. Resorbable membranes dominate the market as they are bio-compatible and get absorbed in the body after the bone formation.
PEST Analysis
Political: Government regulations regarding the usage of substitutes will influence the market. Economic: Rising income levels and growing dental healthcare spending will boost the market. Social: Increasing awareness about oral healthcare and aesthetic dental procedures will drive the market. Technological: Developments in materials science facilitating advanced substitutes will support the market.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing cases of dental diseases, accidents and growing medical tourism.
The North American region dominates the dental membrane and bone graft substitute market accounting for over 30% share owing to increasing dental expenditure and presence of key players. The Asia Pacific region is expected to exhibit the fastest growth in the market during the forecast period owing to the rising incidences of dental caries, increasing healthcare expenditure and growing medical tourism in emerging countries such as India and China.
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
